MOH — authorised 1 May 1984
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
MOH authorised Micronase on 1 May 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 1 May 1984.
SANOFI AVENTIS US holds the Israeli marketing authorisation.